ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive: In our cohort, CML patients carrying the A allele of ABCG2 rs2231142 had lower probability of developing TKI resistance, according to allele, genotype, haplotype (H5), and genotypic (GP17) profile frequencies, and their associated OR values (Figure 2a).